Found 7 matching trials
Comparing the Efficacy of Reverse Hybrid Therapy and Concomitant Therapy NA Reverse hybrid therapy achieves a higher eradication rate than concomitant ...
Show More Location
Kaohsiung Veterans General Hospital
Learn More & Join Trial
Comparing the Efficacy of Reverse Hybrid Therapy and Bismuth Quadruple Therapy NA Reverse hybrid therapy achieves a higher eradication rate than bismuth quad...
Show More Location
Kaohsiung Veterans General Hospital
Learn More & Join Trial
Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in Egyptians PHASE4 Our study aimed to investigate the efficacy and safety of hybrid regimen as...
Show More Learn More & Join Trial
Tailored Juice-guided Eradication Therapy NA In this study, the investigators aim to investigate the efficacy of tailore...
Show More Location
Kaohsiung Medical University Hospital
Learn More & Join Trial
Concomitant Versus Hybrid Regimen for H. Pylori Eradication PHASE4 10 day concomitant versus 14 day hybrid regimen as first line H. pylori era...
Show More Location
Alexandra General Hospital
Learn More & Join Trial
This Clinical Trial is a Single-arm, Non-randomized Pilot Trial to Determine the Safety of Administering Autologous Anti-C19 Cells (ARI-0001) and the Feasibility of Local CAR-T Cell Production in Patients Over 18 Years of Age With Relapsed/Refractory (R/R) CD19+ Hematologic Malignancies, Including R NA This is a hybrid type two study, with two simultaneous development phases. ...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies PHASE3 Both hybrid and high-dose dual therapies developed by the scholars from Tai...
Show More Location
Kaohsiung Veterans General Hospital
Learn More & Join Trial